Description of Event or Problem · 1
DOSI-FUSER (GRIFOLS) IS AN ELASTOMERIC INFUSER THAT WAS IMPLEMENTED AS A REPLACEMENT FOR THE CADD PRISZM PUMPS. CURRENTLY, WE HAVE APPROXIMATELY 5-10 PATIENTS PER WEEK THAT IS USING DOSI-FUSER. THE TYPICAL REGIMEN CALLS FOR THE MEDICATION TO BE GIVEN OVER 46 HOURS. THERE IS A STANDARD DEVIATION OF PLUS/MINUS 10 PERCENT VARIABILITY FOR INFUSION TIME. OVER A TWO-WEEK PERIOD FROM (B)(6) 2016 6 OUT OF 14 PATIENTS EXPERIENCED EARLY COMPLETION OF THEIR INFUSIONS WITH THE DOSI-FUSER, WITH COMPLETION TIMES RANGING FROM 5 HOURS TO 9.5 HOURS AHEAD OF SCHEDULE. WITH A PLANNED INFUSION TIME OF 46 HOURS, A STANDARD DEVIATION OF PLUS/MINUS 10 PERCENT WOULD ALLOW NORMAL VARIATION WITHIN 4.6 HOURS. EARLY COMPLETION TIMES OF 5-9.5 HOURS AHEAD OF PLAN EXCEED THE STANDARD DEVIATION. INTERNAL INVESTIGATION CONFIRMED THAT THE MEDICATIONS FOR INFUSION WERE PREPARED AND PACKAGED CORRECTLY AND THAT THE DOSI-FUSERS WERE PREPARED CORRECTLY. INTERNAL INVESTIGATION ALSO CONFIRMED THAT NURSING STAFF APPLIED THE DOSI-FUSERS TO THE PATIENTS CORRECTLY AND WITH THE APPROPRIATE TECHNIQUE. NONE OF THE 6 PATIENTS EXPERIENCED ANY HARM, ALTHOUGH THE POTENTIAL FOR HARM EXISTS AND HAS BEEN DEEMED SIGNIFICANT ENOUGH TO REMOVE THE DOSI-FUSERS FROM SERVICE IN FAVOR OF ALTERNATIVE MEANS OF HOME INFUSION.